This 20mg blend combines BPC-157 (a gastric pentadecapeptide) with TB-500 (a thymosin beta-4 active fragment) in a single lyophilized preparation for research examining the intersection of cytoprotective signaling and actin-mediated cellular processes. Published literature has documented the distinct but potentially complementary mechanisms of these two well-characterized peptides.
BPC-157’s documented interactions with nitric oxide and growth factor signaling, combined with TB-500’s role in actin sequestration and cytoskeletal dynamics, provide researchers with a dual-mechanism preparation for tissue biology investigations. The blended format simplifies experimental protocols involving concurrent exposure to both compounds.
Both peptide components are individually verified within the blend through chromatographic separation and mass spectrometric analysis. The preparation maintains the stability and purity characteristics of each individual component in the lyophilized state.
For research and investigational purposes only. Not intended for human or animal use.
